Shaked, Yuval http://orcid.org/0000-0001-9037-3895
Article History
Accepted: 12 September 2019
First Online: 23 October 2019
Competing interest
: The author is a co-founder of OncoHost, a biotechnology company that utilizes the host response profile in the clinical setting in order to improve anticancer therapies. The author is listed on several patents related to host responses to anticancer drugs.